Building future
worth through data
Creating future worth through data.
worth through data
Total 37 Posts
-
Director AppointmentAs of November 5, 2007, Mr. Ryu Jeong-seok was appointed Director in charge of Business Planning and Finance.2007.11.07 -
Daehan New Pharm Co., Ltd. holds its 23rd anniversary celebration eventDaehan New Pharm Co., Ltd. 23rd Anniversary Ceremony 1. Date: Saturday, October 20, 2007, 09:00–16:30 2. Venue: Cheongho Human Resources Development Center (located in Hwaseong, Gyeonggi Province) 3. Main Events: Company founding ceremony and sports activities 4. Long-Service Awards (Total of 5 recipients, 10-Year Service Award) 1) Won Hoo-jae, Manager, Quality Control Team, Production Division 2) Kim Young-gil, Assistant Manager, Solid Preparation Team, Production Division 3) Shin Hee-joon, Staff, Facility Team, Production Division 4) Heo Young-soon, Staff, Bio Team, Production Division 5) Kim Soon-hee, Staff, Sales Planning & Management Section, Pharmaceutical Business Division*Award Details: Certificate of merit and a 10-don (approx. 37.5g) pure gold lucky key2007.10.22 -
Implementation of 2007 Outstanding Employee Overseas Training Program1. Purpose: To enhance motivation and company loyalty through overseas training of outstanding employees 2. Training period/location: October 12–16, 2007 (5 days, 3 nights) / Bangkok, Pattaya 3. Number of participants: 16 total, including Manager Lee Eun-woo of the Animal Health Division and 15 others2007.10.11 -
Daehan New Pharm launches the hangover relief product ‘Rus.id’The product contains Vitamin C, succinic acid, and other ingredients. In addition to the original packaging of 6 tablets, a 2-tablet pack for single use has been newly introduced. Daehan New Pharm released ‘Rus.id Anti-F Vitamin C Classic’. This product is a new brand of RU*21, which was first introduced domestically through media coverage in 2004. It has undergone clinical trials at Russia’s national research institute, holds a Russian patent, and is registered with the Russian Ministry of Health. In addition to the original 6-tablet pack, Daehan New Pharm has now launched a single-dose pack containing 2 tablets. According to the company, Rus.id is formulated with vitamin C, succinic acid, fumaric acid, and glutamine, which help eliminate harmful free radicals from the body, suppress and break down acetaldehyde generated by alcohol consumption. Recommended dosage: Take 2 tablets before drinking, 2 tablets two hours later, and 2 tablets the next day to help relieve hangover symptoms. The product is exclusively imported from Russia’s SKS-Aliance and sold through pharmacies. The company also actively engages in sports marketing, including sponsorship of Seongnam Ilhwa, a leading team in Korea’s K-League.2007.07.01 -
Results of the 23rd Annual General Meeting of ShareholdersAgenda Item 1: Approval of the 23rd Fiscal Year Balance Sheet and Income Statement - Approved as Proposed1. Approval of Financial Statements1. Financials for the 23rd Fiscal Year (unit: million KRW)- Total Assets52,440- Sales Revenue52,120- Total Liabilities25,719- Operating Profit3,768- Capital Stock4,300- Net Income for the Period1,632- Total Equity26,721- Earnings Per Share (KRW)190* External Auditor's Opinion: UnqualifiedUnqualifiedAgenda Item 2: Approval of the Appropriation of Retained Earnings for the 23rd Fiscal Year - Approved as Proposed2. Dividend Resolutiona. Cash DividendsDividend per Common Share (KRW)Common ShareYear-end Dividend50Interim/Quarterly Dividends- Preferred SharesYear-end Dividend- Interim/Quarterly Dividends-Total Dividend Amount (KRW)430,000,000Agenda Item 3: Election of Directors - Reappointment of Director Myungrae ParkAgenda Item 4: Election of Auditor - Reappointment of Auditor Seongsook KimAgenda Item 5: Approval of Director Remuneration Limit - Approved as Proposed (KRW 1.5 Billion)Agenda Item 6: Approval of Auditor Remuneration Limit - Approved as Proposed (KRW 100 Million)2007.03.21 -
[Notice] Results of 2006 Drug Reevaluation[Notice] Results of the 2006 Drug Reevaluation In accordance with Article 26-3 and Article 34, Paragraph 4 of the Pharmaceutical Affairs Act and the [Regulations on the Implementation of Drug Reevaluation (KFDA Notification)], a reevaluation was conducted for 636 products across 13 therapeutic classes for blood and body fluids. The results are hereby announced. *** See relevant products below *** Silotal Tab (Cilostazol) [link]Tramin Injection 250 mg (Tranexamic Acid)Tramin Injection 500 mgHerin Injection (Heparin Sodium) For inquiries regarding this notice:Responsible Department: Daehan New Pharm R&D DivisionContact: 02-3415-78572007.01.19 -
22nd Anniversary CelebrationDaehan New Pharm Co., Ltd. (CEO: Park Myung-rae) held its 22nd anniversary ceremony on the 20th in the main auditorium of the headquarters with executives and employees in attendance. During the event, an awards ceremony was held to congratulate and encourage those involved and employees who contributed to the company's development with five employees recognized for 20 and 10 years of long service. In his commemorative speech, CEO Park Myung-rae said, "As we enter the era of youth, let us create a stable profit structure through infinite challenge and continuous effort, and achieve sustainable growth." He presented detailed guidelines for successful development, emphasizing: "First, securing competitiveness by strengthening core competencies in each business division. Second, creating a young and strong company that leads all tasks with passion and audacity. Third, expanding an advanced system to respond swiftly to change. Fourth, constant self-development to cultivate expertise. Finally, open-mindedness among members." He also urged the ceremony to be an occasion for executives and employees to raise their competitiveness to the highest level and commit to a fresh leap forward. At the ceremony, Mr. Kim Ja-seop, staff of the Animal Production Department, received a commendation and a prize of 20 don of gold for 20 years of service. Executive Director Son Young-wook and three others in the Animal Health Business Headquarters received 10-year service awards and a prize of 10 don of gold. In addition, 15 outstanding employees were awarded overseas training in Southeast Asia as a prize.2006.10.20 -
ATAT 2006 EventATAT 2006 Event Held; Commitment to P-3 Implementation From the 7th to the 8th, a two-day experiential team-building POST training titled “Achieving Target All Together (ATAT) 2006” was conducted for all employees to enhance organizational cohesion under the slogan “Let’s Achieve Our Goals Together.” The training held on the 7th at Daegwallyeong Ranch in Hoenggye-gun, Gangwon Province, consisted of a four-stage POST teamwork program aimed at uniting all members, self-contract training to boost confidence and success awareness, and creative problem-solving exercises encouraging teams to solve assigned problems innovatively. Participants pledged to take the lead in change and actively carry out their duties with renewed determination. Based on the slogan “Let’s Achieve Our Goals Together,” the detailed implementation goals of ‘P-3 (Perfect Sale, Perfect Product, Perfect Management)’ were set to strengthen momentum and unity for achieving company objectives. Additionally, a special lecture on “Professionalism” was delivered by Lim Im-taek, a visually impaired full-time instructor at Canaan Farmer School and a featured speaker on MBC’s ‘Exclamation Mark-Street Lecture.’ He shared insights on realizing goals, continuous self-development for a life without regrets, and the true meaning and value of passion in one’s work and profession. The company plans to continue organizing various sports and cultural events involving all employees to foster a new corporate culture.2006.07.10 -
Instructions for Changes to Approval Details (Precautions for Use)Notice of Change Instructions for Approval Details (Precautions for Use) Regarding Glibenclamide Single Ingredient and Others In accordance with the Pharmaceutical Safety Information Management Regulations (KFDA Notification No. 2004-30, dated April 27, 2004), we hereby inform you that change instructions (Pharmaceutical Management Team-13476) have been made to the approval details (precautions for use) of Glibenclamide single ingredient and related products as follows. Ecnic Cream (Hydroquinone) For inquiries regarding this notice: Responsible Department: Daehan New Pharm Development Division Contact Number: 02-3415-78572006.05.18


Home